- Home
- JRI vs ZVRA Comparison
JRI vs ZVRA Comparison
Compare JRI & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JRI
- ZVRA
- Stock Information
- Founded
- JRI 2012
- ZVRA 2006
- Country
- JRI United States
- ZVRA United States
- Employees
- JRI N/A
- ZVRA N/A
- Industry
- JRI Finance Companies
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- JRI Finance
- ZVRA Health Care
- Exchange
- JRI Nasdaq
- ZVRA Nasdaq
- Market Cap
- JRI 349.3M
- ZVRA 400.8M
- IPO Year
- JRI N/A
- ZVRA 2015
- Fundamental
- Price
- JRI $12.84
- ZVRA $7.97
- Analyst Decision
- JRI
- ZVRA Strong Buy
- Analyst Count
- JRI 0
- ZVRA 8
- Target Price
- JRI N/A
- ZVRA $22.29
- AVG Volume (30 Days)
- JRI 68.0K
- ZVRA 440.6K
- Earning Date
- JRI 01-01-0001
- ZVRA 05-13-2025
- Dividend Yield
- JRI 9.38%
- ZVRA N/A
- EPS Growth
- JRI N/A
- ZVRA N/A
- EPS
- JRI N/A
- ZVRA N/A
- Revenue
- JRI N/A
- ZVRA $23,612,000.00
- Revenue This Year
- JRI N/A
- ZVRA $267.44
- Revenue Next Year
- JRI N/A
- ZVRA $90.10
- P/E Ratio
- JRI N/A
- ZVRA N/A
- Revenue Growth
- JRI N/A
- ZVRA N/A
- 52 Week Low
- JRI $9.70
- ZVRA $4.20
- 52 Week High
- JRI $12.12
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- JRI 52.94
- ZVRA 56.48
- Support Level
- JRI $12.90
- ZVRA $7.72
- Resistance Level
- JRI $13.20
- ZVRA $8.11
- Average True Range (ATR)
- JRI 0.19
- ZVRA 0.34
- MACD
- JRI 0.02
- ZVRA 0.06
- Stochastic Oscillator
- JRI 52.00
- ZVRA 73.06
About JRI Nuveen Real Asset Income and Growth Fund of Beneficial Interest
Nuveen Real Asset Income and Growth Fund is the United States-based closed-end fund. Its objective is to provide a high level of current income and long-term capital appreciation. The fund invests a majority of its managed assets in equity and debt securities issued by real asset related companies located anywhere in the world. Its strategy involves investments in five security types, infrastructure common stock, REIT preferred stock and debt securities. Real asset-related companies include those engaged in owning, operating, or developing infrastructure projects, facilities, and services, as well as REITs.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.